Sustained release of melatonin: A novel approach in elevating efficacy of tamoxifen in breast cancer treatment

Colloids and Surfaces B: Biointerfaces

Volumn 145, Issue , 2016, Pages 64-71

  Sabzichi, Mehdi ^a,b   Samadi, Nasser ^a   Mohammadian, Jamal ^b   Hamishehkar, Hamed ^a   Akbarzadeh, Maryam ^c   Molavi, Ommoleila ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; MCF 7; Melatonin; Nano structured lipid carrier (NLC); Tamoxifen

Indexed keywords

CELL DEATH; CELL PROLIFERATION; CELLS; CYTOLOGY; DIFFERENTIAL SCANNING CALORIMETRY; DISEASES; DRUG PRODUCTS; FOURIER TRANSFORMS; GENE EXPRESSION; GENES; INFRARED SPECTROSCOPY; PARTICLE SIZE; POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY;

FOURIER TRANSFORMS INFRARED SPECTROSCOPIES; MCF-7; MELATONIN; NANO-STRUCTURED; NANOSTRUCTURED LIPID CARRIERS; NARROW SIZE DISTRIBUTIONS; REAL-TIME QUANTITATIVE PCR; TAMOXIFEN;

HORMONES;

DRUG CARRIER; MELATONIN; NANOSTRUCTURED LIPID CARRIER; PROTEIN BCL 2; PROTEIN BID; SURVIVIN; TAMOXIFEN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG EFFICACY; DRUG RELEASE; DRUG STABILITY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IC50; INFRARED SPECTROSCOPY; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; SUSTAINED RELEASE FORMULATION; ZETA POTENTIAL; BREAST TUMOR; CHEMISTRY; DRUG EFFECTS; FEMALE; MCF-7 CELL LINE; METABOLISM;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL PROLIFERATION; DRUG CARRIERS; FEMALE; HUMANS; MCF-7 CELLS; MELATONIN; TAMOXIFEN;

EID: 84964515387     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2016.04.042     Document Type: Article

References (42)

1. Youlden D.R., Cramb S.M., Dunn N.A., Muller J.M., Pyke C.M., Baade P.D. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012, 36:237-248.
2. Miao J., Du Y.-Z., Yuan H., Zhang X.-g., Hu F.-Q. Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells. Colloids Surf. B 2013, 110:74-80.
3. Cabeza L., Ortiz R., Arias J.L., Prados J., Martínez M.A.R., Entrena J.M., Luque R., Melguizo C. Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles. Int. J. Nanomed. 2015, 10:1291.
4. Network C.G.A. Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70.
5. Shargh V.H., Hondermarck H., Liang M. Antibody-targeted biodegradable nanoparticles for cancer therapy. Nanomedicine 2016, 11:63-79.
6. Hardeland R., Cardinali D.P., Srinivasan V., Spence D.W., Brown G.M., Pandi-Perumal S.R. Melatonin-a pleiotropic orchestrating regulator molecule. Prog. Neurobiol. 2011, 93:350-384.
7. Reiter R.J., Tan D.-X., Manchester L.C., Paredes S.D., Mayo J.C., Sainz R.M. Melatonin and reproduction revisited. Biol. Reprod. 2009, 81:445-456.
8. Borin T.F., Arbab A.S., Gelaleti G.B., Ferreira L.C., Moschetta M.G., Jardim-Perassi B.V., Iskander A., Varma N.R.S., Shankar A., Coimbra V.B. Melatonin decreases breast cancer metastasis by modulating Rho- associated kinase protein- 1 expression. J. Pineal Res. 2016, 60:3-15.
9. Ju H.Q., Li H., Tian T., Lu Y.X., Bai L., Chen L.Z., Sheng H., Mo H.Y., Zeng J.B., Deng W. Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor- κB activation. J. Pineal Res. 2016, 60:27-38.
10. Reiter R.J., Tan D.x., Sainz R.M., Mayo J.C., Lopez-Burillo S. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J. Pharm. Pharmacol. 2002, 54:1299-1321.
11. Hill S.M., Frasch T., Xiang S., Yuan L., Duplessis T., Mao L. Molecular mechanisms of melatonin anticancer effects. Integr. Cancer Ther. 2009, 8:337-346.
12. Chuffa L.G.A., Alves M.S., Martinez M., Camargo I.C.C., Pinheiro P.F., Domeniconi R.F., Júnior L.A.L., Martinez F.E. Apoptosis is triggered by melatonin in an in vivo model of ovarian carcinoma. Endocr. Relat. Cancer 2016, 23:65-76.
13. Pariente R., Pariente J.A., Rodríguez A.B., Espino J. Melatonin sensitizes human cervical cancer HeLa cells to cisplatin-induced cytotoxicity and apoptosis: effects on oxidative stress and DNA fragmentation. J. Pineal Res. 2016, 60:55-64.
14. Koşar P.A., Naziroğlu M., Övey I.S., Çiğ B. Synergic effects of doxorubicin and melatonin on apoptosis and mitochondrial oxidative stress in MCF-7 breast cancer cells: involvement of TRPV1Channels. J. Membr. Biol. 2015, 1-12.
15. Kim J.H., Jeong S.J., Kim B., Yun S.M., Choi D.Y., Kim S.H. Melatonin synergistically enhances cisplatin- induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK- OV- 3 cells. J. Pineal Res. 2012, 52:244-252.
16. Schaffazick S., Pohlmann A., De Cordova C., Creczynski-Pasa T., Guterres S. Protective properties of melatonin-loaded nanoparticles against lipid peroxidation. Int. J. Pharm. 2005, 289:209-213.
17. Hara C.d.C.P., Honorio-França A.C., Fagundes D.L.G., Guimarães P.C.L., França E.L. Melatonin nanoparticles adsorbed to polyethylene glycol microspheres as activators of human colostrum macrophages. J. Nanomater. 2013, 2013.
18. Mihailiasa M., Caldera F., Li J., Peila R., Ferri A., Trotta F. Preparation of functionalized cotton fabrics by means of melatonin loaded β-cyclodextrin nanosponges. Carbohydr. Polym 2016, 142:24-30.
19. Liu X., Zhang Z., Jiang Y., Hu Y., Wang Z., Liu J., Feng R., Zhang J., Huang G. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation. Drug Deliv. 2015, 22:223-229.
20. Alam T., Pandit J., Vohora D., Aqil M., Ali A., Sultana Y. Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy. Expert Opin. Drug Deliv. 2015, 12:181-194.
21. Junyaprasert V.B., Teeranachaideekul V., Souto E.B., Boonme P., Müller R.H. Q 10-loaded NLC versus nanoemulsions: stability, rheology and in vitro skin permeation. Int. J. Pharm. 2009, 377:207-214.
22. Üner M. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Die Pharm. Int. J. Pharm. Sci. 2006, 61:375-386.
23. Leonardi A., Bucolo C., Drago F., Salomone S., Pignatello R. Cationic solid lipid nanoparticles enhance ocular hypotensive effect of melatonin in rabbit. Int. J. Pharm. 2015, 478:180-186.
24. Xu Z., Chen L., Gu W., Gao Y., Lin L., Zhang Z., Xi Y., Li Y. The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials 2009, 30:226-232.
25. Wang J., Xiao X., Zhang Y., Shi D., Chen W., Fu L., Liu L., Xie F., Kang T., Huang W. Simultaneous modulation of COX- 2, p300, Akt, and Apaf- 1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells. J. Pineal Res. 2012, 53:77-90.
26. Queiroz E.A., Puukila S., Eichler R., Sampaio S.C., Forsyth H.L., Lees S.J., Barbosa A.M., Dekker R.F., Fortes Z.B., Khaper N. Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells. PLoS One 2014, 9:e98207.
27. Minaei A., Sabzichi M., Ramezani F., Hamishehkar H., Samadi N. Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells. Mol. Biol. Rep. 2016, 43:99-105.
28. M.W. Pfaffl, Quantification strategies in real-time PCR, AZ of quantitative PCR, 1 2004 89-113.
29. Lu J.-J., Fu L., Tang Z., Zhang C., Qin L., Wang J., Yu Z., Shi D., Xiao X., Xie F. Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells. Oncotarget 2015.
30. Joo S.S., Yoo Y.M. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer. J. Pineal Res. 2009, 47:8-14.
31. Hill S.M., Belancio V.P., Dauchy R.T., Xiang S., Brimer S., Mao L., Hauch A., Lundberg P.W., Summers W., Yuan L. Melatonin: an inhibitor of breast cancer. Endocr. Relat. Cancer 2015, 22:R183-R204.
32. Mao L., Dauchy R.T., Blask D.E., Dauchy E.M., Slakey L.M., Brimer S., Yuan L., Xiang S., Hauch A., Smith K. Melatonin suppression of aerobic glycolysis (Warburg effect), survival signalling and metastasis in human leiomyosarcoma. J. Pineal Res. 2015.
33. Alonso-González C., González A., Martínez-Campa C., Menéndez-Menéndez J., Gómez-Arozamena J., García-Vidal A., Cos S. Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis. Cancer Lett. 2016, 370:145-152.
34. Suzuki R., Omata D., Oda Y., Unga J., Negishi Y., Maruyama K. Cancer therapy with nanotechnology-based drug delivery systems: applications and challenges of liposome technologies for advanced cancer therapy. Nanomater. Pharmacol. 2016, 457-482.
35. Estanqueiro M., Amaral M.H., Conceição J., Lobo J.M.S. Nanotechnological carriers for cancer chemotherapy: the state of the art. Colloids Surf. B 2015, 126:631-648.
36. Talluri S.V., Kuppusamy G., Reddy Karri V.V.S., Tummala S., Madhunapantula S.V. Lipid-based nanocarriers for breast cancer treatment - comprehensive review. Drug Deliv. 2015, 1-15.
37. Hafner A., Lovrić J., Voinovich D., Filipović-Grčić J. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers. Int. J. Pharm. 2009, 381:205-213.
38. Huang Y., He L., Liu W., Fan C., Zheng W., Wong Y.-S., Chen T. Selective cellular uptake and induction of apoptosis of cancer-targeted selenium nanoparticles. Biomaterials 2013, 34:7106-7116.
39. Martín-Renedo J., Mauriz J.L., Jorquera F., Ruiz-Andrés O., González P., González-Gallego J. Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J. Pineal Res. 2008, 45:532-540.
40. Shen C.-J., Chang C.-C., Chen Y.-T., Lai C.-S., Hsu Y.-C. Melatonin suppresses the growth of ovarian cancer cell lines (OVCAR-429 and PA-1) and potentiates the effect of G1 arrest by targeting CDKs. Int. J. Mol. Sci. 2016, 17:176.
41. Rubio S., Estévez F., Cabrera J., Reiter R.J., Loro J., Quintana J. Inhibition of proliferation and induction of apoptosis by melatonin in human myeloid HL-60 cells. J. Pineal Res. 2007, 42:131-138.
42. Bejarano I., Redondo P.C., Espino J., Rosado J.A., Paredes S.D., Barriga C., Reiter R.J., Pariente J.A., Rodríguez A.B. Melatonin induces mitochondrial- mediated apoptosis in human myeloid HL- 60 cells. J. Pineal Res. 2009, 46:392-400.